MicroRNA Research Tools, Diagnostics and Therapeutics Global Market Research Report 2023

Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The miRNA tools market has observed moderate growth recently and is predicted to grow at a CAGR of 5.9% from 2023 to 2028

In a pursuit to comprehensively understand and evaluate the global landscape of miRNA research tools, diagnostics, and therapeutics, this research study embarks on a mission to forecast revenues, predict future trends, and deliver strategic recommendations for the triumph of market participants. Concentrating its lens on the expansive realm of miRNA tools, this study delves into a contemporary exploration that unveils their applications across diverse spheres of diagnostics and therapeutics.

This report traverses the technologically enriched domain of miRNA tools, encompassing the array of techniques employed within the biomedical industry. Encompassing products such as miRNA quantitative reverse transcription-PCR, next-generation sequencing, microarray, fluorescent in situ hybridization, isolation and purification tools, as well as inhibitors, probes, and vectors, this analysis casts a wide net to capture the comprehensive tapestry of miRNA's potential.

At the heart of this exploration lies the pivotal role of microRNAs (miRNAs), noncoding RNA entities that orchestrate gene silencing and posttranscriptional gene expression regulation. Underpinning thousands of human protein-coding genes' regulatory mechanisms, miRNAs wield influence over fundamental cellular functions, encompassing apoptosis, proliferation, and differentiation - attributes that underscore their involvement in conditions ranging from cancer to cardiovascular diseases.

These attributes elevate miRNAs to the realm of promising diagnostic and therapeutic candidates. With over 2,500 mature microRNAs cataloged in the human genome, the potency of miRNA research hinges upon cutting-edge tools and technologies designed to facilitate exploration into this intricate landscape.

Several tools and technologies are used in the miRNA research continuum, from isolation through discovery, profiling, quantitation, validation and functional analysis. Sensitive and advanced laboratory analysis methods [quantitative reverse transcription polymerase chain reaction (RT- qPCR), next-generation sequencing (NGS), and microarray] and tools (probes, reagents, and kits) for miRNA isolation, discovery, profiling, quantitation, validation and functional analysis are being largely used globally.

Most known miRNAs have been identified by random cloning and sequencing. There is an estimated 0.01% chance of uncovering a unique miRNA using this method - thus making discovery efforts very time-consuming and laborious. Recent studies have focused on bioinformatics, where algorithms predict miRNAs based on the presence of hairpins and other structures associated with the presence of miRNAs.

The need for new research tools is constant as users deepen scientific understanding and search for the next breakthrough. MiRNA profiling is quickly becoming a promising technique in many research fields, such as translational research. It can provide useful information on the role of miRNAs in the pathogenesis of human diseases such as cancers, metabolic diseases, neurological disorders and infectious diseases.

The miRNA tools market growth is attributed to increased research at the genetic level, increased use of miRNA for therapeutic and diagnostic research purposes, the rise in R&D funding, and increased demand for advanced analysis techniques and assay methods. Microarray technology and the advent of NGS in the early 2000s significantly broadened our understanding of miRNAs and introduced new opportunities for clinical applications.

The report also includes an analysis of leading and emerging competitors in the current worldwide miRNA research tools, diagnostics and therapeutics market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development, are analyzed to define the specific product strategies employed. This report also assesses emerging trends and technologies in the market.

Report Includes

  • An up-to-date overview and industry analysis of the global markets for microRNA (miRNA) research tools, diagnostics and therapeutics
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the actual market size and revenue forecast for the global miRNA tools markets, and corresponding market share analysis based on technology type, application (therapeutic area), end user, and region
  • Updated information on key market drivers and opportunities, industry shifts and regulations, and other region and industry specific macroeconomic variables that will influence this market demand in the coming years (2023-2028)
  • Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
  • Review of the selected new miRNA products, research tools and diagnostics services, recent drug candidates, clinical trial applications, and new trends and developments in the biomedical industry
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in various arenas of diagnostics and therapeutics, including cancer, hepatitis infections, and cardiovascular diseases etc.
  • Identification of leading and emerging competitors in the current worldwide market for miRNA research tools, diagnostics, and therapeutics, and analysis of their competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the leading global players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., F. Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific Inc.

Key Attributes:

Report AttributeDetails
No. of Pages200
Forecast Period2023 - 2028
Estimated Market Value (USD) in 2023$664.2 Million
Forecasted Market Value (USD) by 2028$883 Million
Compound Annual Growth Rate5.9%
Regions CoveredGlobal

Key Topics Covered:

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Methodology and Information Sources
  • What's New in this Update?
  • Geographic Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Highlights of the Micro-rna Research Tools, Diagnostics and Therapeutics Markets

Chapter 3 Market Overview

  • Background: Genetic Material
  • Types of Rna
  • Messenger Rna (Mrna)
  • Ribosomal Rna (Rrna)
  • Transfer Rna (Trna)
  • Small Interfering Rnas (Sirna)
  • Small Nucleolar Rna (Snorna)
  • Piwi-Interacting Rnas (Pirnas)
  • Micrornas (Mirnas)
  • Overview
  • History of Microrna Research
  • Biogenesis of Microrna
  • The Function of Microrna
  • Applications of Microrna
  • Research Tools
  • Microrna in Therapeutics
  • Microrna in Diagnostics
  • Bioinformatics: Applications in Microrna Research
  • Computational Tools
  • Mirdb
  • Targetscan
  • Diana-Microt-Cds
  • Mirtargetlink 2.0
  • Rna22 V2
  • Targetminer
  • Rnahybrid
  • Microrna Databases
  • Mirbase
  • Deepbase
  • Mirnamap
  • Plant Microrna Database (Pmrd)

Chapter 4 Market Dynamics

  • Market Drivers
  • Developments in Analytical Technologies and Assay Methods
  • Robust Funding Environment for Biomedical Research
  • Increasing Incidence of Chronic Diseases
  • Growing Number of Clinically Relevant Mirnas
  • Market Challenges
  • High Investment Cost
  • High Failure Rate
  • Challenges Associated With Microrna Based Therapeutics Development
  • Lack of Skilled Professionals

Chapter 5 Market Breakdown by Technology Type

  • Market Overview
  • Quantitative Reverse Transcription Polymerase Chain Reaction (Rt-Qpcr)
  • Next-Generation Sequencing (Ngs)
  • Microarray
  • Isolation and Purification Tools
  • In Situ Hybridization (Ish) and Northern Blotting
  • Other Mirna Tools
  • Microrna Mimics
  • Microrna Inhibitors
  • Agomirs/Antagomirs
  • Market Revenue by Technology Type
  • Rt-Qpcr
  • Next-Generation Sequencing (Ngs)
  • Microarray
  • Isolation and Purification Tools
  • In Situ Hybridization (Ish) and Northern Blotting
  • Other Tools

Chapter 6 Market Breakdown by End-user

  • Market Overview
  • Academic and Other Research Institutes
  • Life Science Industry
  • Therapeutics
  • Diagnostics
  • Mirna Service Providers
  • Market Revenue by End-user
  • Academic and Other Research Institutes Market, by Technology Type
  • Life Science Industry Market, by Technology Type
  • Mirna Service Providers Market, by Technology Type

Chapter 7 Market Breakdown by Application

  • Market Overview
  • Cancer
  • Cardiovascular Diseases
  • Neurological Disorders
  • Metabolic Diseases
  • Immune Disorders
  • Other Diseases
  • Market Revenue by Application
  • Cancer
  • Cardiovascular Diseases
  • Neurological Disorders
  • Metabolic Disorders
  • Immune Disorders
  • Other Diseases

Chapter 8 Market Breakdown by Region

  • Market Overview
  • Market Revenue by Region & Technology Type
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (Row)

Chapter 9 Esg Development

  • Introduction to Esg
  • Sustainability in Mirna Tools and Services Industry: An Esg Perspective
  • Key Esg Issues
  • Consumer Attitudes Towards Esg
  • Industry Esg Performance Analysis
  • Case Study
  • Concluding Remarks

Chapter 10 Emerging Trends and Technologies

  • Emerging Technologies and Trends in the Market
  • Circulating Mirna Diagnostics for Non-Invasive Health Monitoring
  • Increasing Adoption of Digital Pcr (Dpcr)
  • Rna-Sequencing

Chapter 11 Clinical Trials Analysis

  • Overview
  • Pipeline Analysis

Chapter 12 Competitive Landscape

  • Overview
  • Leading Market Players Ranking
  • Mergers and Acquisitions

Chapter 13 Company Profiles

  • Abcam plc
  • Agilent Technolgies Inc.
  • Bio-Rad Laboratories Inc.
  • Cd Genomics
  • Danaher
  • F. Hoffmann-La Roche AG
  • Genecopoeia Inc.
  • Illumina Inc.
  • Merck Kgaa
  • Nanostring Technologies Inc.
  • Qiagen
  • Regulus Therapeutics
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc.

For more information about this report visit https://www.researchandmarkets.com/r/qjqzb3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global MicroRNA Research Tools, Diagnostics & Therapeutics Market